Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Madison Air President & CEO Jill Wyant Talks IPO Plans, Data Infrastructure
09:44

BlackRock Global Fixed Income CIO Rick Rieder Talks Equities
09:43

Kering CEO Luca de Meo Talks Iran War, ICCF
10:54